Pfizer’s 2022 sales top $100 billion but end to COVID-19 bonanza imminent

By CI&T
13 Mar 2023

US drugmaker Pfizer (NYSE: PFE) cemented its place at the top of the pile of global pharma companies in delivering its 2022 financial results.

Comment by Carolina Wosiack for The Pharma Letter

Business

Latest news